Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA3 | P07451 | 1/20 | 0.41 |
| ▸ | CA4 | P22748 | 1/20 | 0.41 |
| ▸ | CA6 | P23280 | 1/20 | 0.41 |
| ▸ | CA5A | P35218 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphine SCHEMBL28308716 | 0.98 | HTR6 (0.42) | HTR6KMT2AALDH1A1KDM4EMAPT | |
| Hydrogen Sulfide SCHEMBL28252271 | 0.98 | HTR6 (0.42) | HTR6KMT2AALDH1A1KDM4EMAPT | |
| Methane SCHEMBL29217844 | 0.98 | HTR6 (0.42) | HTR6KMT2AALDH1A1KDM4EMAPT | |
| Toluene SCHEMBL27667565 | 0.90 | LMNA (0.44) | KMT2AALDH1A1KDM4EMAPTLMNA | |
| SCHEMBL11436284 | 0.89 | TTR (0.41) | HTR6KMT2AALDH1A1KDM4EMAPT | |
| SCHEMBL27289399 | 0.89 | KMT2A (0.37) | HTR6KMT2AALDH1A1KDM4EMAPT | |
| SCHEMBL10886227 | 0.89 | TTR (0.41) | HTR6KMT2AALDH1A1KDM4EMAPT | |
| SCHEMBL11219005 | 0.89 | KMT2A (0.50) | KMT2AALDH1A1KDM4EMAPTLMNA | |
| SCHEMBL10823807 | 0.88 | CA1 (0.43) | ALDH1A1MAPTLMNACA1CA2 | |
| SCHEMBL2724222 | 0.88 | CA12 (0.48) | ALDH1A1CA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1090 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12459193-B2 | Method and kit for non-destructive in situ repair (relining) of deteriorated pipelines | APPLIED RESIN S L (ES) | 2025-11-04 | — | — | US | claimed |
| US-12460123-B2 | Sulfonyl azide composition for sulfur scavenging in oilfield operations | CAMERON INTERNATIONAL CORPORATION (US) | 2025-11-04 | — | — | US | claimed |
| US-20250326759-A1 | PROCESS FOR PREPARING 1-[5-TERT-BUTYL-3-[(1-METHYLTETRAZOL-5-YL)METHYL]TRIAZOLO[4,5-D]PYRIMIDIN-7-YL]PYRROLIDIN-3-OL | HOFFMANN-LA ROCHE INC. (US) | 2025-10-23 | — | — | US | claimed |
| US-20250263596-A1 | SULFONYL AZIDE COMPOSITION FOR SULFUR SCAVENGING IN OILFIELD OPERATIONS | CAMERON INTERNATIONAL CORPORATION | 2025-08-21 | — | — | US | claimed |
| EP-4590784-A1 | SULFONYL AZIDE COMPOSITION FOR SULFUR SCAVENGING IN OILFIELD OPERATIONS | Cameron Technologies Limited (NL) | 2025-07-30 | — | — | EP | claimed |
| CN-119943896-A | Composite positive electrode material and preparation method and application thereof | 深圳市德方纳米科技股份有限公司 | 2025-05-06 | — | — | CN | claimed |
| EP-4536663-A1 | A PROCESS FOR PREPARING 1-[5-TERT-BUTYL-3-[(1-METHYLTETRAZOL-5 -YL)METHYL]TRIAZOLO[4,5-D]PYRIMIDIN-7-YL]PYRROLIDIN-3-OL | F. Hoffmann-La Roche AG (CH) | 2025-04-16 | — | — | EP | claimed |
| EP-4225557-B1 | METHOD AND KIT FOR NON-DESTRUCTIVE IN SITU REPAIR (RELINING) OF DETERIORATED PIPELINES | APPLIED RESIN S L (ES) | 2025-02-19 | — | — | EP | claimed |
| CN-119463589-A | Ultralow-thermal-conductivity self-rebound heat-insulation protective coating and protective coating | 江苏苏博特新材料股份有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-119325477-A | Process for the preparation of 1- [ 5-tert-butyl-3- [ (1-methyltetrazol-5-yl) methyl ] triazolo [4,5-d ] pyrimidin-7-yl ] pyrrolidin-3-ol | 豪夫迈·罗氏有限公司 | 2025-01-17 | — | — | CN | claimed |
| US-20030013696-A1 | Methods and compositions for photo-cross linking photoactive compounds to target tissue | BRITISH COLUMBIA, UNIVERSITY OF, THE (CA) | 2003-01-16 | — | — | US | claimed |
| US-6506908-B2 | From bicyclo(3.1.0)hexabe; decyclization; decarboxylation | MERCK & CO., INC. | 2003-01-14 | — | — | US | claimed |
| WO-2002076453-A1 | METHODS AND COMPOSITIONS FOR PHOTO-CROSS LINKING PHOTOACTIVE COMPOUNDS TO TARGET TISSUE | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2002-10-03 | — | — | WO | claimed |
| US-20020016492-A1 | Process for preparing 3-hydroxymethyl-4-(aryl or heterocyclic)-cyclopentanones | MERCK SHARP & DOHME CORP. | 2002-02-07 | — | — | US | claimed |
| US-5795701-A | Making of microlithographic structures with an underlayer film containing a thermolyzed azide compound | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 1998-08-18 | — | — | US | claimed |
| US-5783361-A | Microlithographic structure with an underlayer film containing a thermolyzed azide compound | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 1998-07-21 | — | — | US | claimed |
| EP-0501294-B1 | Radiation-sensitive polymers with 2-diazo-1,3-dicarbonyl groups, process for its production and its use in a positive-working recording material | HOECHST AG (DE) | 1994-10-26 | — | — | EP | claimed |
| US-5326826-A | Binder | HOECHST AKTIENGESELLSCHAFT (DE) | 1994-07-05 | — | — | US | claimed |
| EP-0501294-A1 | Radiation-sensitive polymers with 2-diazo-1,3-dicarbonyl groups, process for its production and its use in a positive-working recording material | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-09-02 | — | — | EP | claimed |
| US-4640885-A | BECOMES SOLVENT INSOLUBLE WHEN EXPOSED TO ULTRAVIOLET LIGHT | ARMSTRONG WORLD INDUSTRIES, INC. (US) | 1987-02-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250326759-A1 | PROCESS FOR PREPARING 1-[5-TERT-BUTYL-3-[(1-METHYLTETRAZOL-5-YL)METHYL]TRIAZOLO[4,5-D]PYRIMIDIN-7-YL]PYRROLIDIN-3-OL | THPO, TPMT, TPP1 | HTR6 2051/4885KMT2A 2498/4885ALDH1A1 798/4885 |
| US-20020016492-A1 | Process for preparing 3-hydroxymethyl-4-(aryl or heterocyclic)-cyclopentanones | CCR1, CCR5, CCR6 | HTR6 855/4885KMT2A 3504/4885ALDH1A1 2952/4885 |
| US-20030013696-A1 | Methods and compositions for photo-cross linking photoactive compounds to target tissue | LCP1, PPOX, TYR | HTR6 2570/4885KMT2A 3404/4885ALDH1A1 542/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.